Fragment-Based Drug Discovery: A Practical Approach
Zartler
€ 220.98
FREE Delivery in Ireland
Description for Fragment-Based Drug Discovery: A Practical Approach
Hardcover. Fragment-based drug discovery is a faster, cheaper, smarter way to do drug discovery. Emphasizing practical guidance, with procedures, case studies, practical tips, and contributions from industry, Fragment-Based Drug Discovery is a comprehensive guide to the techniques and practice of using fragments in drug screening. Editor(s): Zartler, Edward; Shapiro, Michael. Num Pages: 296 pages, Illustrations. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 247 x 169 x 21. Weight in Grams: 686.
Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery.
Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery.
Fragment-Based Drug Discovery: A Practical Approach is a guide to the techniques and practice of using fragments in drug screening. The emphasis is on practical guidance, with procedures, case studies, practical tips, and contributions from industry. Topics covered include:
- an ... Read more
- setting up an FBDD project
- library building and production
- NMR in fragment screening and follow up
- application of protein-ligand NOE matching to the rapid evaluation of fragment binding poses
- target immobilized NMR screening: validation and extension to membrane proteins
- in situ fragment-based medicinal chemistry: screening by mass spectrometry
- computational approaches to fragment and substructure discovery and evaluation
- virtual fragment scanning: current trends, applications and web based tools
- fragment-based lead discovery using covalent capture methods
- case study from industry: the identification of high affinity beta-secretase inhibitors using fragment-based lead generation
With contributions from industry experts who have successfully set up an industrial fragment-based research program, Fragment-Based Drug Discovery: A Practical Approach offers essential advice to anyone embarking on drug discovery using fragments and those looking for a new approach to screening for drugs.
Show LessProduct Details
Format
Hardback
Publication date
2008
Publisher
John Wiley & Sons Inc United Kingdom
Number of pages
296
Condition
New
Number of Pages
296
Place of Publication
New York, United States
ISBN
9780470058138
SKU
V9780470058138
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50
About Zartler
Edward R. Zartler, Strategy Consultant, Eli Lilly & Co.; Established the Fragment-based Drug Design paradigm at Eli Lilly. Michael J. Shapiro, Associate Professor of Pharmacy, University of Maryland School of Pharmaceutical Sciences; Industry experience at Lilley, Novartis and Sandoz.
Reviews for Fragment-Based Drug Discovery: A Practical Approach
"This is a useful book for readers already familiar with the basic aspects of drug design and discovery." (ChemMedChem, October 2009) "This book provides an excellent resource for those in pharmaceutical research who are interested in fragment-based drug discovery. Most of the topics are covered in enough detail that this book could be used as a guide for ... Read more